Back
Apellis Pharmaceuticals Stock Predictions
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
39.81
Seasonality Move:
-5.11%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer3.jpg)
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.Apellis Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 22% based on the past 6 years of stock performance.
- Apellis Pharmaceuticals has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $38.88. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 22% based on the past 6 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
- Apellis Pharmaceuticals has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
73.80
52-Week Low:
19.83
Prediction Charts
Market Cap:
4.72B
Price in USD:
38.88
Volume:
1.69M
Beta:
0.85
Technical Analysis
SMA50:
39.79
SMA100:
46.48
SMA200:
52.12
52-Wk Change:
28.66%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company. -
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 38.88 USD today. -
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jul-8 | 36.62 | 37.01 | 37.43 | 36.12 |
Jul-9 | 37.00 | 37.54 | 37.90 | 36.84 |
Jul-10 | 37.72 | 37.44 | 38.23 | 36.72 |
Jul-11 | 38.00 | 38.90 | 39.92 | 37.96 |
Jul-12 | 38.98 | 39.53 | 40.98 | 38.98 |
Jul-15 | 39.71 | 40.02 | 40.46 | 39.04 |
Jul-16 | 40.73 | 41.15 | 42.47 | 40.12 |
Jul-17 | 40.32 | 39.50 | 41.81 | 39.46 |
Jul-18 | 39.78 | 37.95 | 39.84 | 36.56 |
Jul-19 | 37.90 | 37.98 | 38.59 | 37.32 |
Jul-22 | 38.44 | 37.05 | 38.59 | 36.30 |
Jul-23 | 36.74 | 36.88 | 37.66 | 36.54 |
Jul-24 | 36.43 | 37.38 | 38.55 | 36.43 |
Jul-25 | 37.22 | 38.88 | 39.74 | 37.22 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.27 per share, an increase this year of $3.51 per share, and an increase next year of $1.98 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.